The API manufacturing site is AstraZeneca’s largest investment into in the state of Virginia to date, and will produce ADCs ...

BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.

Marketing and manufacturing practices for compounded GLP-1RA drugs come under FDA scrutiny, prompting policy changes.

Turbine and AstraZeneca have partnered to enhance the discovery of antibody-drug conjugates (ADCs) using the former’s virtual ...

Data from England’s National Health Service (NHS) shows that the flu jab has been administered to 4.3 million people, a 28% ...

Celltrion has received approval from the US Food and Drug Administration (FDA) for the biosimilar product, Eydenzelt ...

The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody ...

The FDA’s growing aversion to advisory committees stokes concerns around the transparency and scientific grounding of decisions.

Novo Nordisk has agreed to buy Akero Therapeutics in a deal rising to a potential $5.2bn, as the Danish drugmaker looks to ...

Amazon Pharmacy kiosks will stock commonly used drugs such as antibiotics, inhalers, and blood pressure medications.

To address this, many warehouse operations managers are turning to automation, including robotics, to reduce the strain on ...

Peter Marks joins former FDA colleague, Rachael Anatol at Eli Lilly, becoming the second agency worker the pharma has snapped ...